Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comprehensive SRS Regenerex Tissue Attachment

NCT: NCT06615739 · COMPLETED

NCT IDNCT06615739
StatusCOMPLETED
Start Date2024-10-22
Completion2026-02-26
SponsorZimmer Biomet (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

Frequently Asked Questions

What is Comprehensive SRS Regenerex Tissue Attachment?

Comprehensive SRS Regenerex Tissue Attachment is a clinical trial registered under NCT06615739. Current status: COMPLETED.

What is the status of NCT06615739?

The current status of NCT06615739 (Comprehensive SRS Regenerex Tissue Attachment) is: COMPLETED.

When did Comprehensive SRS Regenerex Tissue Attachment start?

Comprehensive SRS Regenerex Tissue Attachment started on 2024-10-22.

Related Devices

K173411Comprehensive Segmental Revision System (SRS)Biomet Manufacturing Corp K223631Comprehensive Segmental Revision System(SRS)Biomet Orthopedics

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑